| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 36,9 M € | +44.4% | 25,6 M € | +19.0% | 21,5 M € | +14.3% | 18,8 M € | -10.6% | 21,0 M € | +11.0% | 18,9 M € | +2.4% | 18,5 M € | +24.8% | 14,8 M € | +7.7% | 13,8 M € | +8.3% | 12,7 M € | +38.0% | 9,2 M € | +28.1% | 7,2 M € | +27.0% | 5,7 M € | +16.9% | 4,8 M € | +66.4% | 2,9 M € | +18.5% | 2,5 M € | +16.7% | 2,1 M € | +0.0% | 2,1 M € | |
| EBITDA | 3,6 M € | -1.4% | 3,7 M € | +2.1% | 3,6 M € | +6.6% | 3,4 M € | -18.9% | 4,2 M € | +19.0% | 3,5 M € | -28.0% | 4,9 M € | +6.9% | 4,6 M € | +4.2% | 4,4 M € | +2.3% | 4,3 M € | +22.6% | 3,5 M € | +135.0% | 1,5 M € | +175.9% | 540,6 k € | +2.1% | 529,2 k € | +61.6% | 327,5 k € | +39.0% | 235,6 k € | -28.9% | 331,2 k € | +79.2% | 184,8 k € | |
| Operating profit | 2,1 M € | -3.4% | 2,1 M € | +2.1% | 2,1 M € | +2.2% | 2,0 M € | -30.7% | 3,0 M € | +25.4% | 2,4 M € | -38.7% | 3,8 M € | +8.2% | 3,6 M € | -13.5% | 4,1 M € | +3.4% | 4,0 M € | +20.0% | 3,3 M € | +163.1% | 1,3 M € | +313.8% | 304,2 k € | +27.4% | 238,8 k € | +31.5% | 181,6 k € | +14.0% | 159,3 k € | -35.1% | 245,6 k € | +170.1% | 90,9 k € | |
| Profit/loss | 2,9 M € | +119.4% | -15,2 M € | -3072.6% | 509,7 k € | +50.1% | 339,5 k € | -64.6% | 958,4 k € | +104.7% | -20,5 M € | +37.0% | -32,6 M € | -2629.2% | 1,3 M € | -91.5% | 15,1 M € | +2185.1% | -724,5 k € | -166.9% | 1,1 M € | +35.7% | 797,7 k € | +336.3% | 182,8 k € | +23.9% | 147,6 k € | +26.4% | 116,7 k € | +13.5% | 102,9 k € | -33.2% | 154,1 k € | +180.1% | 55,0 k € | |
| Equity | 124,5 M € | +2.4% | 121,5 M € | -11.1% | 136,7 M € | +4592.4% | 2,9 M € | -53.6% | 6,3 M € | -39.2% | 10,3 M € | -73.8% | 39,3 M € | -45.3% | 71,9 M € | -12.4% | 82,1 M € | +22.5% | 67,0 M € | +0.5% | 66,7 M € | +3451.0% | 1,9 M € | +73.9% | 1,1 M € | +20.4% | 897,1 k € | +19.7% | 749,5 k € | +18.5% | 632,8 k € | +19.4% | 529,9 k € | +41.0% | 375,8 k € | |
| Total assets | 132,3 M € | +3.3% | 128,1 M € | -11.2% | 144,3 M € | -0.9% | 145,7 M € | -2.1% | 148,8 M € | -2.4% | 152,5 M € | -15.5% | 180,4 M € | -15.3% | 213,0 M € | -4.7% | 223,5 M € | +9.2% | 204,6 M € | +0.3% | 203,9 M € | +7658.5% | 2,6 M € | +51.5% | 1,7 M € | -0.6% | 1,7 M € | +10.6% | 1,6 M € | +68.4% | 937,0 k € | +1.2% | 926,3 k € | +1.9% | 909,3 k € | |
| Cash | 804,8 k € | +23.9% | 649,5 k € | +30.2% | 498,7 k € | -30.3% | 715,8 k € | -12.5% | 818,0 k € | +23.6% | 661,9 k € | -53.6% | 1,4 M € | -43.2% | 2,5 M € | -86.7% | 18,8 M € | +1902.3% | 940,3 k € | -7.2% | 1,0 M € | -14.3% | 1,2 M € | +248.3% | 339,7 k € | +197.2% | 114,3 k € | +80.7% | 63,3 k € | -65.9% | 185,6 k € | -10.7% | 207,8 k € | +6.1% | 195,9 k € | |
| Debts | 7,8 M € | +20.1% | 6,5 M € | -13.8% | 7,6 M € | -94.7% | 142,6 M € | +0.1% | 142,5 M € | +0.3% | 142,1 M € | +0.7% | 141,1 M € | +0.0% | 141,1 M € | -0.2% | 141,4 M € | +2.8% | 137,6 M € | +0.2% | 137,2 M € | +19082.4% | 715,3 k € | +9.2% | 655,0 k € | -22.8% | 848,0 k € | +2.3% | 828,7 k € | +172.4% | 304,2 k € | -23.3% | 396,5 k € | -25.7% | 533,5 k € | |
| Staff | 47,7 | 54 | 53,8 | 48,3 | 44,8 | 42,9 | 39,7 | 34,1 | 35,8 | 33,8 | 27,2 | 26,5 | 21,8 | 15,7 | 12,1 | 9,6 | 9 | 9,4 | ||||||||||||||||||
Private limited company · Drogenbos · incorporated on 20/05/1998 · 47,7 ETP
Private limited company profitable and well capitalised. Cash position rising (+23.9%).
Solid counterparty for a standard engagement.
CONMED Europe is a Private limited company incorporated in 1998. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Drogenbos. It employs on average 47,7 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette